Protocol for Life Balance GI Guard PM
Natural health product licensed in Canada
- Licence holder
- NOW Health Group, Inc.
- NPN or DIN-HM
- 80055241
- Status
- Active licence
- Licence date
- 29 October 2014
- Revision date
- Not provided
- Form
- Capsule végétale
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : Acide folique | 400 mcg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 12.5 mg | Not calculated |
| [N-bêta-alanyl-L-histidinato(2-)-N,NN,Oalpha]zinc Source : Synthétique Potency : 8 mg Zinc | Not specified | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Synthétique | 50 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 25 mcg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 3 mg | Not calculated |
| L-Methionine Source : DL-méthionine | 50 mg | Not calculated |
| 1-Carboxy-N,N,N-sel interne de triméthylméthanaminium Source : Chlorhydrate de bétaine | 50 mg | Not calculated |
| L-tryptophane Source : Synthétique | 100 mg | Not calculated |
| [N-bêta-alanyl-L-histidinato(2-)-N,NN,Oalpha]zinc Source : Synthétique Potency : 28.5 mg L-Carnosine | 37.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Cellulose microcristalline, Cellulose hydroxypropyl méthyl ether, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule e.g. shift work and jet lag. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80055241
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.